Search Results - "Posma, Jens J"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases by Posma, Jens J, Grover, Steven P, Hisada, Yohei, Owens, A Phillip, Antoniak, Silvio, Spronk, Henri M, Mackman, Nigel

    “…Activation of the blood coagulation cascade leads to fibrin deposition and platelet activation that are required for hemostasis. However, aberrant activation…”
    Get full text
    Journal Article
  2. 2

    Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice by Posthuma, Jelle J., Posma, Jens J. N., van Oerle, Rene, Leenders, Peter, van Gorp, Rick H., Jaminon, Armand M. G., Mackman, Nigel, Heitmeier, Stefan, Schurgers, Leon J., ten Cate, Hugo, Spronk, Henri M. H.

    Published in Scientific reports (07-03-2019)
    “…Atherosclerosis is a progressive inflammatory vascular disorder, complicated by plaque rupture and subsequently atherothrombosis. In vitro studies indicate…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Effect of combining aspirin and rivaroxaban on atherosclerosis in mice by Grover, Steven P., Coughlin, Taylor, Fleifil, Salma M., Posma, Jens J.N., Spronk, Henri H.M., Heitmeier, Stefan, Owens, A. Phillip, Mackman, Nigel

    Published in Atherosclerosis (01-03-2022)
    “…The platelet inhibitor aspirin reduces inflammation and atherosclerosis in both apolipoprotein E deficient (apoE−/−) mice and low-density lipoprotein receptor…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Protease-activated receptors are potential regulators in the development of arterial endofibrosis in high-performance athletes by Posthuma, Jelle J., Posma, Jens J.N., Schep, Goof, Bender, Mart M.H., van Oerle, Rene, van der Wal, Allard C., ten Cate, Hugo, Spronk, Henri M.H.

    Published in Journal of vascular surgery (01-04-2019)
    “…High-performance athletes can develop symptomatic arterial flow restriction during exercise caused by endofibrosis. The pathogenesis is poorly understood;…”
    Get full text
    Journal Article
  7. 7

    Thrombin-mediated activation of PAR1 enhances doxorubicin-induced cardiac injury in mice by Grover, Steven P., Bharathi, Vanthana, Posma, Jens J., Griffin, John H., Palumbo, Joseph S., Mackman, Nigel, Antoniak, Silvio

    Published in Blood advances (23-05-2023)
    “…•Cardiomyocyte and cardiac fibroblast PAR1 contribute to doxorubicin-induced cardiac injury.•PAR1 cleavage at R41 confers pathologic Galphaq signaling during…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Roles of Coagulation Proteases and Protease-activated Receptors in Mouse Models of Inflammatory Diseases by Posma, Jens J, Grover, Steven P, Hisada, Yohei, Owens, A. Phillip, Antoniak, Silvio, Spronk, Henri M, Mackman, Nigel

    “…Activation of the blood coagulation cascade leads to fibrin deposition and platelet activation that are required for hemostasis. However, aberrant activation…”
    Get full text
    Journal Article
  10. 10

    Abstract 328: Coagulation Proteases are Potential Regulators in the Development of Exercise-Related Endofibrosis by Posthuma, Jelle J, Posma, Jens J, Schep, Goof, Bender, Mart, van Oerle, Rene, ten Cate, Hugo, Spronk, Henri M

    “…Abstract only Background: High performance athletes can develop symptomatic arterial flow restriction during exercise, caused by endofibrosis. The disease is…”
    Get full text
    Journal Article
  11. 11